A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/20/2002	CN1094492C Process for preparing 'Xidinafei' medicine
11/20/2002	CN1094491C 2-{4-[4-(4,5-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and use thereof
11/20/2002	CN1094490C Quinolein-2(1H)-one derivativs as serotonin antagonists
11/20/2002	CN1094486C Benzal compound and preparation method
11/20/2002	CN1094373C Medicine for curing pernio and its preparing method
11/20/2002	CN1094354C Nafiverine injection
11/20/2002	CN1094353C Pharmaceutical formulations containing beta-lactamasa inhibiting penem in combination with beta-lactam antibiotic and their use in treatment of bacterial infections
11/20/2002	CN1094352C Composition for treating and preventing sudden death of chicken
11/20/2002	CN1094351C External-use medicine 'Gujiasan' powder and its preparing method
11/20/2002	CN1094350C Preparation for epidermis and process for its preparation
11/20/2002	CN1094349C Pharmaceutical composition
11/20/2002	CN1094348C Compound multiple vitamin drop for infant
11/20/2002	CN1094347C Release-controlled micropill for treating benign prostatic hyperplasis and its preparing method
11/20/2002	CN1094346C Preparation method of microlipid granule for wrapping medicine
11/20/2002	CN1094345C High dose liposomal aerosol formulations
11/20/2002	CN1094326C Carotenoid preparation having mixture of beta-carotene, ycopene and xanthophyll
11/20/2002	CN1094324C Cancer chemoprotective food products
11/20/2002	CN1094313C 饱腹食品 Satiating food
11/19/2002	US6482986 Benzene derivatives, preparation method and pharmaceutical compositions containing same
11/19/2002	US6482956 Endothelin receptor antagonists
11/19/2002	US6482951 Isoindolin-1-one glucokinase activators
11/19/2002	US6482942 Method of isolating mucilaginous polysaccharides and uses thereof
11/19/2002	US6482939 Form vi 5,6-dichloro-2-(isopropylamino)-1-(β-l-ribofuranosyl)-1h-bezimimidazole
11/19/2002	US6482929 Antibodies to ARF-p19
11/19/2002	US6482920 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
11/19/2002	US6482865 Method for preparing colloidal solution of bismuth sodium tartrate
11/19/2002	US6482862 Method of using substituted N-benzyl-N-phenyl aminoalcohols for inhibiting cholesteryl ester transfer protein activity
11/19/2002	US6482861 Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
11/19/2002	US6482860 Pentafluorobenzenesulfonamides and analogs
11/19/2002	US6482858 (−)-hydroxycitric acid for wound healing and immunomodulation
11/19/2002	US6482857 Compositions which contain triterpenes for regulating hair growth
11/19/2002	US6482856 Method and composition for treating mammalian disease caused by inflammatory response
11/19/2002	US6482855 Oxidation resistance; stress relieving
11/19/2002	US6482854 Glaucoma treatment
11/19/2002	US6482853 Lactate thiolester for cardiac energy resuscitation and prevention of reperfusion injury and use as an energy supplement during exercise and recovery
11/19/2002	US6482852 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
11/19/2002	US6482851 Synthesis of dysidiolide and uses thereof
11/19/2002	US6482849 Inhibitors of α4β1 mediated cell adhesion
11/19/2002	US6482848 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/19/2002	US6482847 3-(1-methyl-3-indolyl)-4-(1-methyl-6-nitro-3-indolyl)-1h -pyrrole-2,5-dione anticarcinogenic agents
11/19/2002	US6482846 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/19/2002	US6482845 Method for inhibiting interleukin-2 production using tricyclo compounds
11/19/2002	US6482843 Compounds and methods for use thereof in the treatment of cancer or viral infections
11/19/2002	US6482842 3-aminopyrazole inhibitors of cyclin dependent kinases
11/19/2002	US6482841 Pyridyl compounds and pharmaceutical compositions containing them
11/19/2002	US6482839 Pyridine-thiols for treatment of a follicular dermatosis
11/19/2002	US6482838 Cholinesterase inhibitor
11/19/2002	US6482837 Antimuscarinic compounds and methods for treatment of bladder diseases
11/19/2002	US6482836 CRF antagonistic quino- and quinazolines
11/19/2002	US6482835 Such as (r)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxyl ic acid methanesulfonate; chemical intermediates; bactericides; catalysis
11/19/2002	US6482834 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
11/19/2002	US6482833 Spermine antagonists inhibit the inhibitory effect of spermine upon macrophage function, and prevent spermine induced immunosuppression; combination of a bispiperidine a diamine or dinitrile
11/19/2002	US6482832 Heterocyclically substituted amides, their production and their use
11/19/2002	US6482831 Covalently coupled benzoylecgonine, egconine and ecgonidine derivatives
11/19/2002	US6482830 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
11/19/2002	US6482829 Central nervous system disorders; heeadaches, antiinflammatory agents
11/19/2002	US6482826 Method of treating alopecia
11/19/2002	US6482825 Growth-hormone secretagogues
11/19/2002	US6482824 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists
11/19/2002	US6482823 Taste masked pharmaceutical liquid formulations
11/19/2002	US6482822 N-(iminomethyl)amines derivatives, their preparation, their use as medicines and compositions containing them
11/19/2002	US6482820 Benzazepine-n-acetic acid derivatives which contain an oxo-group in the alpha- position to the nitrogen atom and are substituted in position 3 by a 1-(carboxyalkyl)cyclo-entylcarbonylamino radical
11/19/2002	US6482819 2,3-benzodiazepine derivatives
11/19/2002	US6482818 C-2 S/O-and S/N formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and β-lactamase inhibitors
11/19/2002	US6482816 Organic arsenic compounds
11/19/2002	US6482815 Organic-arsenic compounds
11/19/2002	US6482813 Steroids substituted at the 11-position, process for their preparation, their use as medicament and the pharmaceutical compositions containing them
11/19/2002	US6482812 Method of locking 1α-OH of vitamin D compounds in axial orientation
11/19/2002	US6482811 Bretylium compositions and kits, and their use in preventing and treating cardio-vascular conditions
11/19/2002	US6482810 Antibiotic composition for inhibition of angiogenesis
11/19/2002	US6482809 Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis
11/19/2002	US6482807 LPS with reduced toxicity from genetically modified gram negative bacteria
11/19/2002	US6482806 Product of heat treatment of uronic acid, food, drink, or drug including the product
11/19/2002	US6482802 Use of neomycin for treating angiogenesis-related diseases
11/19/2002	US6482801 Therapy for bacterial or protozoa infections
11/19/2002	US6482623 Lipid kinase
11/19/2002	US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002	US6482609 Isolated human EDG-4 receptor and polynucletide encoding said receptor
11/19/2002	US6482517 Coated particles, methods of making and using
11/19/2002	US6482448 Soy formulations and their use for promoting health
11/19/2002	US6482446 Viscous and low alcohol content; be used for delivering
11/19/2002	US6482440 Long acting antidepressant microparticles
11/19/2002	US6482438 Apparatus and process for preparing crystalline particles
11/19/2002	US6482437 Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations
11/19/2002	US6482434 Method for reducing adverse effects of a weight loss regimen
11/19/2002	US6482429 Stable powder inhalation dosage formulation
11/19/2002	US6482426 Compositions for the treatment of male erectile dysfunction
11/19/2002	US6482425 Parasiticidal combination
11/19/2002	US6482421 Pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
11/19/2002	US6482417 Stable pharmaceutical formulation comprising torsemide modification II
11/19/2002	US6482416 Alteration of macrophage-induced t cell suppression or concentration by the selective elimination or increase of tryptophan by administering an enzyme inhibitor of indole-amino 2,3-deoxygenase; viricides; abortion; fertility;
11/19/2002	US6482402 Antimicrobial compositions and methods
11/19/2002	US6482401 Chondroitin and glucosamine
11/19/2002	US6482396 Combination of lactoferrin (lf) and glycomacropeptide (gmp) that exerts an antimicrobial effect in oral cavities
11/19/2002	US6481435 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage
11/19/2002	CA2332631C Soft gelatin capsule manufacture
11/19/2002	CA2273026C Non-irritating cosmetic and pharmaceutical compositions
11/19/2002	CA2256896C Non-aqueous colonic purgative formulations
11/19/2002	CA2252513C Method for the prevention and treatment of cachexia and anorexia
11/19/2002	CA2251530C Treatment of a hemoglobinopathy

1 ... 5647 5648 5649 5650 5651 5652 5653 5654 5655 5656 5657 5658 5659 5660 5661 5662 5663 5664 5665 5666 5667 ... 7860